Statistics
Publications
8
Citations
872
H-Index
8
Active since
2006
Affiliations
Zhihong Zeng is an author at The University of Texas MD Anderson Cancer Center specializing in hematologic malignancy therapy, medicine, and oncology.
Publications per year
2006–2024
8
8
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zhihong Zeng, Dos D. Sarbassov, Ismael Samudio et al. · Blood · 2006 · 343 citations · Full text
Naval Daver, Yanis Boumber, Hagop M. Kantarjian et al. · Clinical Cancer Research · 2015 · 67 citations · Full text
Medicine, Oncology, Pharmacology +15
Brittany Knick Ragon, Hagop M. Kantarjian, Elias Jabbour et al. · American Journal of Hematology · 2016 · 54 citations · Full text
1–5 of 8